[The pathogens and their antibiotic sensitivities in hospital-acquired pneumonia cases]

Hasan Kaynar1, Nusret Yilmaz, Leyla Sağlam

  • 1Department of Chest Disease, Faculty of Medicine, University of Atatürk, Erzurum, Turkey. hkaynar@atauni.edu.tr

Tuberkuloz Ve Toraks
|November 24, 2004
PubMed

Insights

Early diagnosis and treatment of hospital-acquired pneumonia (HAP) are crucial due to high mortality. Invasive diagnostic methods, like bronchoscopy, are vital when non-invasive approaches fail, aiding pathogen identification and guiding antibiotic resistance management.

Area of Science:

  • Infectious Diseases
  • Critical Care Medicine
  • Pulmonology

Context:

  • Hospital-acquired pneumonia (HAP) presents a significant challenge due to high mortality rates.
  • Clinical and radiological findings, along with non-invasive methods, often prove insufficient for accurate HAP diagnosis.
  • Invasive diagnostic procedures may be necessary for timely and accurate HAP diagnosis in hospitalized patients.

Purpose:

  • To evaluate the necessity and efficacy of invasive diagnostic interventions in hospital-acquired pneumonia.
  • To identify common pathogens and antibiotic resistance patterns in HAP cases.
  • To assess the impact of diagnostic strategies on patient outcomes and mortality.

Summary:

  • A prospective study of 38 HAP patients revealed that 76.3% developed pneumonia after five days of hospitalization.
  • Bronchoscopic interventions were performed in 65.8% of patients, with Staphylococci being the most frequent pathogen (45.4%).
  • High resistance rates to third-generation cephalosporins were observed, and 11 of 17 deaths were pneumonia-attributable.

Impact:

  • Invasive diagnostic methods, though costly, can prevent unnecessary antibiotic use and reduce HAP-related mortality.
  • Determining pathogen and antibiotic resistance is essential for effective HAP management.
  • Timely and accurate diagnosis through invasive procedures improves patient outcomes in critical care settings.

Related Concept Videos

Pneumonia I: Introduction01:29

Pneumonia I: Introduction

Pneumonia is an infection of the lower respiratory tract that leads to inflammation of the lung parenchyma, often resulting in the accumulation of inflammatory exudate in the alveoli and airways. Unlike the watery, low-protein fluid exudate in pulmonary edema, the exudate in this case is a thick fluid rich in immune cells, proteins, and debris produced during infection and inflammation.This impairs gas exchange and can lead to consolidation of lung tissue. The infection may be caused by a...
Pneumonia I: Introduction01:30

Pneumonia I: Introduction

Pneumonia is an acute respiratory infection that targets the lungs, specifically the alveoli. These tiny air sacs, essential for oxygen exchange, become engorged with pus and fluid, severely hindering breathing, decreasing oxygen absorption, and causing significant pain and discomfort during respiration.
Risk Factors
Various factors influence the likelihood of developing pneumonia. Age plays a crucial role, with infants, children under two, and individuals over 65 at increased risk due to their...
Mechanism of Antibiotic Resistance in MRSA01:25

Mechanism of Antibiotic Resistance in MRSA

Antibiotic resistance in bacteria arises when microorganisms evolve the ability to withstand drugs designed to kill them or inhibit their growth, rendering once-effective treatments useless. This phenomenon, driven by genetic change and selection under antibiotic exposure, poses a profound threat to modern medicine. Mechanisms include drug-inactivating enzymes (e.g., β-lactamases), efflux pumps that eject antibiotics, mutations altering antibiotic targets, decreased drug uptake, and acquisition...
Atypical Pneumonia01:14

Atypical Pneumonia

Atypical pneumonia, often caused by Mycoplasma pneumoniae, is a form of pulmonary infection that differs from the classical presentation of bacterial pneumonia in both its cause and clinical symptoms. Mycoplasma pneumoniae is a pleomorphic bacterium notable for its lack of a rigid cell wall. This structural characteristic imparts resistance to beta-lactam antibiotics and significantly influences the bacterium’s behavior within the human host.Other pathogens responsible for the disease include...
Pneumonia III: Complications and Assessment01:30

Pneumonia III: Complications and Assessment

Pneumonia poses the potential for numerous complications that warrant consideration. These complications include the following:
Clinical Significance of Antibiotic Resistance01:25

Clinical Significance of Antibiotic Resistance

Methicillin-resistant Staphylococcus aureus (MRSA) presents a critical public health threat, arising from its capacity to resist β-lactam antibiotics due to acquisition of the mecA gene within the staphylococcal cassette chromosome mec (SCCmec). This gene encodes penicillin-binding protein 2a (PBP2a), which impairs binding efficacy of methicillin and other β-lactams. MRSA has evolved into distinct clonal lineages impacting humans and animals alike, reinforcing its significance within the One...